Get the Stockscreener App
1.59
1.27%
0.02
Pre-market:
1.61
0.02
+1.26%
Compugen Ltd stock is traded at $1.59, with a volume of 186.69K.
It is up +1.27% in the last 24 hours and down -1.24% over the past month.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
See More
Previous Close:
$1.57
Open:
$1.57
24h Volume:
186.69K
Relative Volume:
0.49
Market Cap:
$148.72M
Revenue:
-
Net Income/Loss:
$1.60M
P/E Ratio:
53.00
EPS:
0.03
Net Cash Flow:
$-62.91M
1W Performance:
+0.00%
1M Performance:
-1.24%
6M Performance:
-7.02%
1Y Performance:
+0.00%
1-Day Range:
$1.535
$1.595
1-Week Range:
$1.48
$1.60
52-Week Range:
$1.13
$2.66
Compugen Ltd Stock (CGEN) Company Profile
Compare CGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
1.59 | 146.85M | 0 | 1.60M | -62.91M | 0.03 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-13-25 | Initiated | Oppenheimer | Outperform |
| Aug-05-22 | Downgrade | Jefferies | Buy → Hold |
| May-26-20 | Resumed | JMP Securities | Mkt Outperform |
| May-13-20 | Initiated | Stifel | Buy |
| May-07-20 | Initiated | SVB Leerink | Outperform |
| Apr-22-20 | Initiated | ROTH Capital | Buy |
| Mar-24-20 | Initiated | SunTrust | Buy |
| Jan-16-20 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-29-18 | Initiated | Oppenheimer | Outperform |
| Feb-01-16 | Resumed | Oppenheimer | Outperform |
| Oct-15-15 | Initiated | FBR Capital | Outperform |
| Apr-23-15 | Resumed | Jefferies | Buy |
| Apr-21-15 | Initiated | Oppenheimer | Outperform |
| Feb-07-14 | Initiated | MLV & Co | Buy |
| Dec-28-09 | Reiterated | Cantor Fitzgerald | Buy |
| Jul-29-09 | Initiated | Cantor Fitzgerald | Buy |
View All
Compugen Ltd Stock (CGEN) Latest News
Compugen Presents Promising COM701 Analysis at ESMO 2025 - MSN
Compugen’s Former Head Reflects on Computational Discovery, Strategic Collaborations And AI - Citeline News & Insights
Compugen Ltd (CGEN) Stock Price & 30 Year Financial Data - GuruFocus
Compugen (NASDAQ:CGEN) versus PepGen (NASDAQ:PEPG) Critical Review - Defense World
Can Compugen Ltd. stock beat analyst upgrades2025 Risk Factors & AI Based Buy and Sell Signals - newser.com
What indicators show strength in Compugen Ltd.Layoff News & Fast Momentum Entry Tips - newser.com
Is Compugen Ltd. stock oversold or undervaluedJuly 2025 Trade Ideas & Community Verified Trade Alerts - newser.com
What high frequency data says about Compugen Ltd.July 2025 Action & High Accuracy Trade Signal Alerts - newser.com
Real time social sentiment graph for Compugen Ltd.Portfolio Risk Report & Reliable Entry Point Trade Alerts - newser.com
How interest rate cuts could boost Compugen Ltd. stockQuarterly Market Summary & Verified Swing Trading Watchlist - newser.com
Is now a turning point for Compugen Ltd.Stock Surge & AI Driven Price Predictions - newser.com
Can Compugen Ltd. rally from current levelsQuarterly Trade Review & Free Community Supported Trade Ideas - newser.com
What catalysts could drive Compugen Ltd. stock higherMarket Performance Summary & Fast Entry Momentum Alerts - newser.com
How to interpret RSI for Compugen Ltd. stockChart Signals & Consistent Profit Alerts - newser.com
Analyzing recovery setups for Compugen Ltd. investors2025 Biggest Moves & Step-by-Step Swing Trade Plans - newser.com
Compugen (NASDAQ:CGEN) Stock Rating Upgraded by Wall Street Zen - Defense World
Does Compugen Ltd. qualify in momentum factor screeningEarnings Summary Report & AI Forecast Swing Trade Picks - newser.com
FY2025 EPS Estimates for Compugen Boosted by Leerink Partnrs - Defense World
Is Compugen Ltd. stock a top pick in earnings seasonOptions Play & Scalable Portfolio Growth Ideas - newser.com
Reversal indicators forming on Compugen Ltd. stockBull Run & Low Drawdown Trading Strategies - newser.com
Compugen Ltd Stock (CGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):